Restart Life Sciences Corp.

NMLSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$11$8$267$219
Short-Term Investments$159$0$0$0
Receivables$11$7$8$70
Inventory$0$0$0$0
Other Curr. Assets$0$5$8$39
Total Curr. Assets$181$20$282$328
Property Plant & Equip (Net)$9$11$14$18
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$535
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$9$11$14$553
Other Assets$0$0$0$0
Total Assets$190$31$297$881
Liabilities
Payables$194$387$119$398
Short-Term Debt$80$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$215$455$137$24
Total Curr. Liab.$489$842$255$422
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$489$842$255$422
Equity
Pref Stock$0$0$0$0
Common Stock$50,516$50,193$50,066$48,368
Retained Earnings-$59,064-$59,289-$58,065-$55,599
AOCI$8,249$8,286$8,032$7,690
Other Equity$0$0$8$0
Total Equity-$299-$811$41$459
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$190$31$297$881
Net Debt$69-$8-$267-$219
Restart Life Sciences Corp. (NMLSF) Financial Statements & Key Stats | AlphaPilot